The first in human pilot study has been designed as an open non-randomized study. Ten patients with pronounced non-ischemic dilated cardiomyopathy were included and treated with a C-MIC system. The study will be completed in April 2020 (last patient out). First results showing overwhelming effects of microcurrent application. Details will be published in a scientific journal in the very near future after completion of the study.